ES8406192A1 - Procedimiento para la obtencion de un medio antimicotico en forma de sistemas de gel con alta liberalizacion de la sus-tancia activa - Google Patents

Procedimiento para la obtencion de un medio antimicotico en forma de sistemas de gel con alta liberalizacion de la sus-tancia activa

Info

Publication number
ES8406192A1
ES8406192A1 ES527566A ES527566A ES8406192A1 ES 8406192 A1 ES8406192 A1 ES 8406192A1 ES 527566 A ES527566 A ES 527566A ES 527566 A ES527566 A ES 527566A ES 8406192 A1 ES8406192 A1 ES 8406192A1
Authority
ES
Spain
Prior art keywords
active ingredient
high active
ingredient release
gel systems
antimycotic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES527566A
Other languages
English (en)
Other versions
ES527566A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8406192A1 publication Critical patent/ES8406192A1/es
Publication of ES527566A0 publication Critical patent/ES527566A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE UN MEDIO ANTIMICOTICO EN FORMA DE SISTEMAS DE GEL CON ALTA LIBERACION DE LA SUSTANCIA ACTIVA.CONSISTE EN MEZCLAR UNO O VARIOS DERIVADOS AZOLICOS ANTIMICOTICOS, UN 1-5 DE ALCOHOL BENCILICO, UN 2,5-35 DE AGENTE DE ESPARCION Y COMO FORMADOR DE GEL UN 10-30 DE ALCOHOL CETILESTEARILICOS CON APROXIMADAMENTE 30 MOLES DE OXIDO ETILENICO, SE FUNDE A 110JC BAJO GASIFICACION CON NITROGENO, SE REUNE BAJO PRESION CON LA FASE ACUOSA (100JC) Y BAJO LENTA AGITACION SE ENFRIA A 25JC. LOS DERIVADOS AZOLICOS ANTIMICOTICOS PUEDEN SER: UNAMEZCLA DE CLOTRIMAZOL DE FORMULA (A); UNA MEZCLA DE BIFONAZOL DE FORMULA (B); UNA MEZCLA DE LOMBAZOL DE FORMULA (C).
ES527566A 1982-11-27 1983-11-25 Procedimiento para la obtencion de un medio antimicotico en forma de sistemas de gel con alta liberalizacion de la sus-tancia activa Granted ES527566A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823244027 DE3244027A1 (de) 1982-11-27 1982-11-27 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von gelsystemen

Publications (2)

Publication Number Publication Date
ES8406192A1 true ES8406192A1 (es) 1984-08-01
ES527566A0 ES527566A0 (es) 1984-08-01

Family

ID=6179276

Family Applications (1)

Application Number Title Priority Date Filing Date
ES527566A Granted ES527566A0 (es) 1982-11-27 1983-11-25 Procedimiento para la obtencion de un medio antimicotico en forma de sistemas de gel con alta liberalizacion de la sus-tancia activa

Country Status (11)

Country Link
EP (1) EP0113009A3 (es)
JP (1) JPS59108713A (es)
KR (1) KR840006767A (es)
AR (1) AR231397A1 (es)
CA (1) CA1209916A (es)
DE (1) DE3244027A1 (es)
DK (1) DK541783A (es)
ES (1) ES527566A0 (es)
HU (1) HU187612B (es)
IL (1) IL70320A0 (es)
NO (1) NO834083L (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61151117A (ja) * 1984-12-25 1986-07-09 Bayer Yakuhin Kk 抗真菌ゲル製剤
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
JPH01242525A (ja) * 1988-03-25 1989-09-27 Nippon Nohyaku Co Ltd 抗真菌外用剤
JPH01246219A (ja) * 1988-03-25 1989-10-02 Nippon Nohyaku Co Ltd 抗真菌外用クリーム組成物
DE4234188C2 (de) * 1992-10-10 1996-01-11 Beiersdorf Ag Antimycotische kosmetische und dermatologische Verwendungen
IT1284874B1 (it) 1996-08-02 1998-05-22 Farmigea Spa Complessi bioadesivi di polycarbophil e farmaci antifungini o antiprotozoari azolici

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52117416A (en) * 1976-03-29 1977-10-01 Nippon Kayaku Co Ltd Novel ointment base
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften
JPS5815909A (ja) * 1981-07-22 1983-01-29 Toko Yakuhin Kogyo Kk 抗真菌外用剤

Also Published As

Publication number Publication date
IL70320A0 (en) 1984-02-29
AR231397A1 (es) 1984-11-30
NO834083L (no) 1984-05-28
DK541783D0 (da) 1983-11-25
HU187612B (en) 1986-02-28
EP0113009A2 (de) 1984-07-11
EP0113009A3 (de) 1985-09-25
JPS59108713A (ja) 1984-06-23
KR840006767A (ko) 1984-12-03
DE3244027A1 (de) 1984-05-30
CA1209916A (en) 1986-08-19
DK541783A (da) 1984-05-28
ES527566A0 (es) 1984-08-01

Similar Documents

Publication Publication Date Title
AU540763B2 (en) Pour on formulation, active against ticks
FI914607A0 (fi) Farmaceutisk blandning i gelform i en dispenserfoerpackning.
GB2074860B (en) Diffusional active agent dispenser
AU553010B2 (en) Device for active ingredient release
AU550992B2 (en) Sustained release diethylpropion comppositions
AR019642A2 (es) Composicion quimica exogena
EP0105635A3 (en) Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therepeutic agents
AU517497B2 (en) Active agent delivery system
NZ298769A (en) use of progesterone-antagonistic and anti-estrogen compounds in a single dose for female contraception
ATE222753T1 (de) Oxybutyninformulierungen mit gesteuerter freisetzung
DK0600544T3 (da) Anvendelse af lycopen til at reducere aktivitet af celler, især af cancerceller, og farmaceutiske præparater
ZA821137B (en) Antimycotic agent,in the form of sticks,with a high release of active compound
ES2095662T3 (es) Derivados de imidazol con actividad antagonista de la angiotensina ii.
ES480426A1 (es) Procedimiento para la obtencion de hidroxipropil-imidazoles.
EP0047122A3 (en) Intranasal formulation
SE8800025D0 (sv) Bioadhesive suppository pharmaceutical preparations
NZ192941A (en) 1-substituted imidazoles;pharmaceutical compositions
ES2060293T3 (es) Nueva sustancia antiulcerosa.
EP0113009A3 (de) Antimykotische Mittel mit hoher Wirkstoff-Freisetzung in Form von Gelsystemen
FI802488A7 (fi) Antimykotiska aineita, jotka vapauttavat enemmän vaikutusaineita.
ES8600260A1 (es) Un procedimiento para preparar derivados de propinilaminotiazol
IE800724L (en) Analgesic and myotonolytic preparations
ES2074178T3 (es) Preparados de antimicoticos externos de imidazol.
ZA838774B (en) Antimycotic agents in gel form for the treatment of fungal infections of the oral cavity
HUT61561A (en) Process for producing octadecyl-/2-(n-methylpiperidino)-ethyl/-phosphate and pharmaceutical compositions comprising same as active ingredient